HALB (Halberd) Other Stockholders Equity: $0.00 Mil (As of Jul. 2023)


What is Halberd Other Stockholders Equity?

Halberd HALB -1.05% Other Stockholders Equity is $0.00 Mil as of Jul. 2023.

Halberd's Other Stockholders Equity for the quarter that ended in Jul. 2023 was $0.00 Mil.

Halberd's quarterly Other Stockholders Equity increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($0.00 Mil) but then declined from Jul. 2022 ($0.00 Mil) to Jul. 2023 ($0.00 Mil).

Halberd's annual Other Stockholders Equity increased from Jul. 2008 ($0.00 Mil) to Jul. 2022 ($0.00 Mil) but then declined from Jul. 2022 ($0.00 Mil) to Jul. 2023 ($0.00 Mil).

Halberd Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Halberd's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Halberd Other Stockholders Equity Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
Other Stockholders Equity
0.00 0.00 0.00

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
Other Stockholders Equity 0.00 0.00 0.00

Halberd Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
Halberd (HALB) has a Other Stockholders Equity of $0.00 Mil as of Jul. 2023. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Halberd and its competitors.
Is Halberd's Other Stockholders Equity too high?
Halberd's current Other Stockholders Equity is $0.00 Mil.
How does Halberd's Other Stockholders Equity compare to GRI and OCEA?
Halberd's Other Stockholders Equity of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Halberd and its competitors. Halberd's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Halberd stock overvalued right now?
Halberd (HALB) has a current Other Stockholders Equity of $0.00 Mil. The current Other Stockholders Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Halberd (HALB), the current Other Stockholders Equity is $0.00 Mil as of Jul. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Halberd Business Description

Address P.O. Box 25, Jackson Center, PA, USA, 16133
Halberd Corp is a holding company and acquisition vehicle for established businesses. It is also developing a patented process for disease eradication by removing the pathophysiologic basis of the disease. The company is focused on developing treatments for neurodegenerative diseases, such as PTSD and CTE (Post Traumatic Stress Disorder and Chronic Traumatic Encephalopathy), Alzheimer's Disease, Parkinson's Disease, etc.